dichlororibofuranosylbenzimidazole has been researched along with Glial Cell Tumors in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, A | 1 |
| Lakka, SS | 1 |
| Mohanam, S | 1 |
| Boyd, D | 1 |
| Rao, JS | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Glial Cell Tumors
| Article | Year |
|---|---|
Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines.
Topics: beta-Galactosidase; Chloramphenicol O-Acetyltransferase; Dichlororibofuranosylbenzimidazole; Electro | 2001 |